NYSE - Nasdaq Real Time Price USD

Credicorp Ltd. (BAP)

Compare
190.60 +3.99 (+2.14%)
At close: October 18 at 4:00 PM EDT
188.65 -1.96 (-1.03%)
After hours: October 18 at 4:06 PM EDT

Research Analysis

Earnings Per Share

Consensus EPS
?

Revenue vs. Earnings

Revenue 4.35B
Earnings 1.34B
?

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
?

Analyst Price Targets

156.64 Low
193.02 Average
190.60 Current
215.38 High

Earnings Estimate

CURRENCY IN USD Current Qtr. (Sep 2024)Next Qtr. (Dec 2024)Current Year (2024)Next Year (2025)
No. of Analysts 5589
Avg. Estimate 4.574.518.3420.54
Low Estimate 4.344.3617.719.68
High Estimate 4.864.6718.8121.02
Year Ago EPS 4.032.7816.0718.34

Revenue Estimate

CURRENCY IN USD Current Qtr. (Sep 2024)Next Qtr. (Dec 2024)Current Year (2024)Next Year (2025)
No. of Analysts 2266
Avg. Estimate 1.41B1.45B5.58B5.95B
Low Estimate 1.41B1.44B5.53B5.87B
High Estimate 1.41B1.45B5.62B6.03B
Year Ago Sales 1.21B1.28B4.94B5.58B
Sales Growth (year/est) 16.70%13.00%12.90%6.60%

Earnings History

CURRENCY IN USD 9/30/2023 12/31/2023 3/31/2024 6/30/2024
EPS Est. 4.292.83.914.72
EPS Actual 4.032.784.974.42
Difference -0.26-0.021.06-0.3
Surprise % -6.10%-0.70%27.10%-6.40%

EPS Trend

CURRENCY IN USD Current Qtr. (Sep 2024)Next Qtr. (Dec 2024)Current Year (2024)Next Year (2025)
Current Estimate 4.574.518.3420.54
7 Days Ago 4.624.5518.5520.77
30 Days Ago 4.54.4618.3620.6
60 Days Ago 4.524.4818.3220.61
90 Days Ago 4.584.3518.5820.53

EPS Revisions

CURRENCY IN USD Current Qtr. (Sep 2024)Next Qtr. (Dec 2024)Current Year (2024)Next Year (2025)
Up Last 7 Days --------
Up Last 30 Days 1112
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

CURRENCY IN USD BAPIndustrySectorS&P 500
Current Qtr. 13.40%----3.70%
Next Qtr. 61.90%----7.90%
Current Year 14.10%----2.50%
Next Year 12.00%----13.10%
Next 5 Years (per annum) 4.16%----11.88%
Past 5 Years (per annum) 17.33%------

Upgrades & Downgrades

Maintains Goldman Sachs: Sell to Sell 10/8/2024
Maintains JP Morgan: Overweight to Overweight 2/29/2024
Maintains UBS: Buy to Buy 2/5/2024
Upgrade JP Morgan: Neutral to Overweight 12/15/2023
Maintains JP Morgan: Neutral to Neutral 11/13/2023
Initiated Jefferies: Buy 10/16/2023

Related Tickers